An array of prescription medications on shelves

Vaccines: A Case for Public Pharma

April 3, 2020
Expanding democratic ownership

Vaccines are critical to safeguarding public health as one of the most effective ways to prevent disease, including highly contagious diseases that can cause pandemics. But the for-profit pharmaceutical industry is neither prepared for nor incentivized to tackle growing public health challenges, like global pandemics.

The downloadable 1 page PDF below, produced in cooperation with the Center for Popular Democracy, makes the case for why we need public pharma to help combat pandemic threats like COVID-19.

Download and read now:

More related work
Default Image

Healthcare as a public service: Redesigning U.S. healthcare with health and equity at the center

by Dana Brown

The Veterans Health Administration—the country’s only fully public, integrated healthcare system—has a lot to tell us about how a national healthcare service for the United States might operate.

read more
Medicine Cost

Americans deserve publicly owned generic drugs

by Dana Brown

Bold policies could have saved America’s largest generic drug plant, but it’s never too late to start putting communities first.

read more
Illustration courtesy of United Nations

All health is public health: Busting the myths of choice and commodity

by Dana Brown

For decades, we have been sold a myth of private health. It is a myth that our health is largely a product of individual choices and personal responsibilities. It is a myth that our healthcare is a service that private corporations can provide, and for which we must pay to survive. But the COVID-19

read more